{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T10:13:35Z","timestamp":1771668815938,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T00:00:00Z","timestamp":1557792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009228","name":"Region \u00d6rebro l\u00e4n","doi-asserted-by":"publisher","award":["OLL-328061"],"award-info":[{"award-number":["OLL-328061"]}],"id":[{"id":"10.13039\/501100009228","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009228","name":"Region \u00d6rebro l\u00e4n","doi-asserted-by":"publisher","award":["OLL-788601"],"award-info":[{"award-number":["OLL-788601"]}],"id":[{"id":"10.13039\/501100009228","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009784","name":"Signe och Olof Wallenius Stiftelse","doi-asserted-by":"publisher","award":["130528"],"award-info":[{"award-number":["130528"]}],"id":[{"id":"10.13039\/501100009784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004200","name":"Stiftelsen Olle Engkvist Byggm\u00e4stare","doi-asserted-by":"publisher","award":["130321"],"award-info":[{"award-number":["130321"]}],"id":[{"id":"10.13039\/501100004200","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003509","name":"\u00d6rebro Universitet","doi-asserted-by":"publisher","award":["OLL-780211"],"award-info":[{"award-number":["OLL-780211"]}],"id":[{"id":"10.13039\/501100003509","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s10096-019-03567-2","type":"journal-article","created":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T23:22:58Z","timestamp":1557876178000},"page":"1425-1434","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Plasma concentrations of secretory leukocyte protease inhibitor (SLPI) differ depending on etiology and severity in community-onset bloodstream infection"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7679-7253","authenticated-orcid":false,"given":"Anna","family":"Lange","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Cajander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Magnuson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas","family":"Sund\u00e9n-Cullberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristoffer","family":"Str\u00e5lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olof","family":"Hultgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,14]]},"reference":[{"issue":"2","key":"3567_CR1","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/01.CCM.0000194725.48928.3A","volume":"34","author":"JL Vincent","year":"2006","unstructured":"Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, Moreno R, Carlet J, Le Gall JR, Payen D (2006) Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 34(2):344\u2013353","journal-title":"Crit Care Med"},{"issue":"8","key":"3567_CR2","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC (2016) The third international consensus definitions for Sepsis and septic shock (Sepsis-3). JAMA 315(8):801\u2013810","journal-title":"JAMA"},{"issue":"3","key":"3567_CR3","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/CCM.0000000000000026","volume":"42","author":"EK Stevenson","year":"2014","unstructured":"Stevenson EK, Rubenstein AR, Radin GT, Wiener RS, Walkey AJ (2014) Two decades of mortality trends among patients with severe sepsis: a comparative meta-analysis*. Crit Care Med 42(3):625\u2013631","journal-title":"Crit Care Med"},{"issue":"2","key":"3567_CR4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ccm.2016.01.002","volume":"37","author":"JA Kempker","year":"2016","unstructured":"Kempker JA, Martin GS (2016) The changing epidemiology and definitions of sepsis. Clin Chest Med 37(2):165\u2013179","journal-title":"Clin Chest Med"},{"issue":"16","key":"3567_CR5","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1056\/NEJMoa022139","volume":"348","author":"GS Martin","year":"2003","unstructured":"Martin GS, Mannino DM, Eaton S, Moss M (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348(16):1546\u20131554","journal-title":"N Engl J Med"},{"issue":"5","key":"3567_CR6","doi-asserted-by":"crossref","first-page":"R202","DOI":"10.1186\/cc12896","volume":"17","author":"J Phua","year":"2013","unstructured":"Phua J, Ngerng W, See K, Tay C, Kiong T, Lim H, Chew M, Yip H, Tan A, Khalizah H, Capistrano R, Lee K, Mukhopadhyay A (2013) Characteristics and outcomes of culture-negative versus culture-positive severe sepsis. Crit Care 17(5):R202","journal-title":"Crit Care"},{"issue":"10","key":"3567_CR7","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1097\/01.CCM.0000239114.50519.0E","volume":"34","author":"AM Esper","year":"2006","unstructured":"Esper AM, Moss M, Lewis CA, Nisbet R, Mannino DM, Martin GS (2006) The role of infection and comorbidity: factors that influence disparities in sepsis. Crit Care Med 34(10):2576\u20132582","journal-title":"Crit Care Med"},{"issue":"6","key":"3567_CR8","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/1469-0691.12144","volume":"19","author":"KB Laupland","year":"2013","unstructured":"Laupland KB (2013) Incidence of bloodstream infection: a review of population-based studies. Clin Microbiol Infect 19(6):492\u2013500","journal-title":"Clin Microbiol Infect"},{"key":"3567_CR9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cytogfr.2015.12.001","volume":"28","author":"M Majchrzak-Gorecka","year":"2016","unstructured":"Majchrzak-Gorecka M, Majewski P, Grygier B, Murzyn K, Cichy J (2016) Secretory leukocyte protease inhibitor (SLPI), a multifunctional protein in the host defense response. Cytokine Growth Factor Rev 28:79\u201393","journal-title":"Cytokine Growth Factor Rev"},{"issue":"18","key":"3567_CR10","doi-asserted-by":"crossref","first-page":"6692","DOI":"10.1073\/pnas.83.18.6692","volume":"83","author":"RC Thompson","year":"1986","unstructured":"Thompson RC, Ohlsson K (1986) Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. Proc Natl Acad Sci U S A 83(18):6692\u20136696","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"3567_CR11","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.1128\/IAI.64.11.4520-4524.1996","volume":"64","author":"PS Hiemstra","year":"1996","unstructured":"Hiemstra PS, Maassen RJ, Stolk J, Heinzel-Wieland R, Steffens GJ, Dijkman JH (1996) Antibacterial activity of antileukoprotease. Infect Immun 64(11):4520\u20134524","journal-title":"Infect Immun"},{"issue":"3","key":"3567_CR12","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1164\/rccm.200804-615OC","volume":"179","author":"SA Gomez","year":"2009","unstructured":"Gomez SA, Arguelles CL, Guerrieri D, Tateosian NL, Amiano NO, Slimovich R, Maffia PC, Abbate E, Musella RM, Garcia VE, Chuluyan HE (2009) Secretory leukocyte protease inhibitor: a secreted pattern recognition receptor for mycobacteria. Am J Respir Crit Care Med 179(3):247\u2013253","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"3567_CR13","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1086\/514098","volume":"176","author":"JF Tomee","year":"1997","unstructured":"Tomee JF, Hiemstra PS, Heinzel-Wieland R, Kauffman HF (1997) Antileukoprotease: an endogenous protein in the innate mucosal defense against fungi. J Infect Dis 176(3):740\u2013747","journal-title":"J Infect Dis"},{"issue":"1","key":"3567_CR14","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1172\/JCI118056","volume":"96","author":"TB McNeely","year":"1995","unstructured":"McNeely TB, Dealy M, Dripps DJ, Orenstein JM, Eisenberg SP, Wahl SM (1995) Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro. J Clin Invest 96(1):456\u2013464","journal-title":"J Clin Invest"},{"issue":"12","key":"3567_CR15","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1084\/jem.20050768","volume":"202","author":"CC Taggart","year":"2005","unstructured":"Taggart CC, Cryan SA, Weldon S, Gibbons A, Greene CM, Kelly E, Low TB, O'Neill SJ, McElvaney NG (2005) Secretory leucoprotease inhibitor binds to NF-kappaB binding sites in monocytes and inhibits p65 binding. J Exp Med 202(12):1659\u20131668","journal-title":"J Exp Med"},{"issue":"37","key":"3567_CR16","doi-asserted-by":"crossref","first-page":"33648","DOI":"10.1074\/jbc.M203710200","volume":"277","author":"CC Taggart","year":"2002","unstructured":"Taggart CC, Greene CM, McElvaney NG, O'Neill S (2002) Secretory leucoprotease inhibitor prevents lipopolysaccharide-induced IkappaBalpha degradation without affecting phosphorylation or ubiquitination. J Biol Chem 277(37):33648\u201333653","journal-title":"J Biol Chem"},{"issue":"4","key":"3567_CR17","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1365-2567.2011.03451.x","volume":"133","author":"D Guerrieri","year":"2011","unstructured":"Guerrieri D, Tateosian NL, Maffia PC, Reiteri RM, Amiano NO, Costa MJ, Villalonga X, Sanchez ML, Estein SM, Garcia VE, Sallenave JM, Chuluyan HE (2011) Serine leucocyte proteinase inhibitor-treated monocyte inhibits human CD4(+) lymphocyte proliferation. Immunology 133(4):434\u2013441","journal-title":"Immunology"},{"issue":"8","key":"3567_CR18","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1182\/blood-2013-06-508887","volume":"123","author":"O Klimenkova","year":"2014","unstructured":"Klimenkova O, Ellerbeck W, Klimiankou M, Unalan M, Kandabarau S, Gigina A, Hussein K, Zeidler C, Welte K, Skokowa J (2014) A lack of secretory leukocyte protease inhibitor (SLPI) causes defects in granulocytic differentiation. Blood 123(8):1239\u20131249","journal-title":"Blood"},{"issue":"1","key":"3567_CR19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1189\/jlb.4AB1114-543R","volume":"98","author":"K Zabieglo","year":"2015","unstructured":"Zabieglo K, Majewski P, Majchrzak-Gorecka M, Wlodarczyk A, Grygier B, Zegar A, Kapinska-Mrowiecka M, Naskalska A, Pyrc K, Dubin A, Wahl SM, Cichy J (2015) The inhibitory effect of secretory leukocyte protease inhibitor (SLPI) on formation of neutrophil extracellular traps. J Leukoc Biol 98(1):99\u2013106","journal-title":"J Leukoc Biol"},{"issue":"6","key":"3567_CR20","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/jlb.61.6.695","volume":"61","author":"JM Sallenave","year":"1997","unstructured":"Sallenave JM, Si Tahar M, Cox G, Chignard M, Gauldie J (1997) Secretory leukocyte proteinase inhibitor is a major leukocyte elastase inhibitor in human neutrophils. J Leukoc Biol 61(6):695\u2013702","journal-title":"J Leukoc Biol"},{"issue":"6","key":"3567_CR21","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1128\/IAI.66.6.2447-2452.1998","volume":"66","author":"F Jin","year":"1998","unstructured":"Jin F, Nathan CF, Radzioch D, Ding A (1998) Lipopolysaccharide-related stimuli induce expression of the secretory leukocyte protease inhibitor, a macrophage-derived lipopolysaccharide inhibitor. Infect Immun 66(6):2447\u20132452","journal-title":"Infect Immun"},{"issue":"10","key":"3567_CR22","doi-asserted-by":"crossref","first-page":"6588","DOI":"10.4049\/jimmunol.179.10.6588","volume":"179","author":"JN Samsom","year":"2007","unstructured":"Samsom JN, van der Marel AP, van Berkel LA, van Helvoort JM, Simons-Oosterhuis Y, Jansen W, Greuter M, Nelissen RL, Meeuwisse CM, Nieuwenhuis EE, Mebius RE, Kraal G (2007) Secretory leukoprotease inhibitor in mucosal lymph node dendritic cells regulates the threshold for mucosal tolerance. J Immunol 179(10):6588\u20136595","journal-title":"J Immunol"},{"issue":"1","key":"3567_CR23","doi-asserted-by":"crossref","first-page":"L51","DOI":"10.1152\/ajplung.2000.278.1.L51","volume":"278","author":"S Wetering van","year":"2000","unstructured":"van Wetering S, van der Linden AC, van Sterkenburg MA, de Boer WI, Kuijpers AL, Schalkwijk J, Hiemstra PS (2000) Regulation of SLPI and elafin release from bronchial epithelial cells by neutrophil defensins. Am J Physiol Lung Cell Mol Physiol 278(1):L51\u2013L58","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"5","key":"3567_CR24","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1097\/00003246-200005000-00003","volume":"28","author":"SR Grobmyer","year":"2000","unstructured":"Grobmyer SR, Barie PS, Nathan CF, Fuortes M, Lin E, Lowry SF, Wright CD, Weyant MJ, Hydo L, Reeves F, Shiloh MU, Ding A (2000) Secretory leukocyte protease inhibitor, an inhibitor of neutrophil activation, is elevated in serum in human sepsis and experimental endotoxemia. Crit Care Med 28(5):1276\u20131282","journal-title":"Crit Care Med"},{"issue":"6","key":"3567_CR25","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3109\/00365548.2012.760844","volume":"45","author":"AL Jendeberg","year":"2013","unstructured":"Jendeberg AL, Stralin K, Hultgren O (2013) Antimicrobial peptide plasma concentrations in patients with community-acquired pneumonia. Scand J Infect Dis 45(6):432\u2013437","journal-title":"Scand J Infect Dis"},{"issue":"2","key":"3567_CR26","doi-asserted-by":"crossref","first-page":"e0192883","DOI":"10.1371\/journal.pone.0192883","volume":"13","author":"S Cajander","year":"2018","unstructured":"Cajander S, Rasmussen G, Tina E, Magnuson A, Soderquist B, Kallman J, Stralin K (2018) Dynamics of monocytic HLA-DR expression differs between bacterial etiologies during the course of bloodstream infection. PLoS One 13(2):e0192883","journal-title":"PLoS One"},{"issue":"3","key":"3567_CR27","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/biomet\/63.3.581","volume":"63","author":"DB Rubin","year":"1976","unstructured":"Rubin DB (1976) Inference and missing data. Biometrika 63(3):581\u2013592","journal-title":"Biometrika"},{"issue":"1","key":"3567_CR28","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/2197-425X-2-6","volume":"2","author":"DJ Cain","year":"2014","unstructured":"Cain DJ, Del Arroyo AG, Ackland GL (2014) Uncontrolled sepsis: a systematic review of translational immunology studies in intensive care medicine. Intensive Care Med Exp 2(1):6","journal-title":"Intensive Care Med Exp"},{"issue":"2","key":"3567_CR29","doi-asserted-by":"crossref","first-page":"R27","DOI":"10.1186\/cc8898","volume":"14","author":"R Abe","year":"2010","unstructured":"Abe R, Oda S, Sadahiro T, Nakamura M, Hirayama Y, Tateishi Y, Shinozaki K, Hirasawa H (2010) Gram-negative bacteremia induces greater magnitude of inflammatory response than Gram-positive bacteremia. Crit Care 14(2):R27","journal-title":"Crit Care"},{"key":"3567_CR30","doi-asserted-by":"crossref","first-page":"11355","DOI":"10.1038\/srep11355","volume":"5","author":"M Surbatovic","year":"2015","unstructured":"Surbatovic M, Popovic N, Vojvodic D, Milosevic I, Acimovic G, Stojicic M, Veljovic M, Jevdjic J, Djordjevic D, Radakovic S (2015) Cytokine profile in severe Gram-positive and Gram-negative abdominal sepsis. Sci Rep 5:11355","journal-title":"Sci Rep"},{"issue":"4","key":"3567_CR31","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/21505594.2016.1144003","volume":"7","author":"WO Hahn","year":"2016","unstructured":"Hahn WO, Mikacenic C, Price BL, Harju-Baker S, Katz R, Himmelfarb J, Wurfel MM, Liles WC (2016) Host derived biomarkers of inflammation, apoptosis, and endothelial activation are associated with clinical outcomes in patients with bacteremia and sepsis regardless of microbial etiology. Virulence 7(4):387\u2013394","journal-title":"Virulence"},{"issue":"5","key":"3567_CR32","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1084\/jem.20021824","volume":"197","author":"A Nakamura","year":"2003","unstructured":"Nakamura A, Mori Y, Hagiwara K, Suzuki T, Sakakibara T, Kikuchi T, Igarashi T, Ebina M, Abe T, Miyazaki J, Takai T, Nukiwa T (2003) Increased susceptibility to LPS-induced endotoxin shock in secretory leukoprotease inhibitor (SLPI)-deficient mice. J Exp Med 197(5):669\u2013674","journal-title":"J Exp Med"},{"issue":"7","key":"3567_CR33","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/00003246-200107000-00002","volume":"29","author":"DC Angus","year":"2001","unstructured":"Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29(7):1303\u20131310","journal-title":"Crit Care Med"},{"issue":"7","key":"3567_CR34","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1046\/j.1469-0691.2003.00582.x","volume":"9","author":"LA Duits","year":"2003","unstructured":"Duits LA, Tjabringa GS, Aarts NJ, van't Wout JW, Hiemstra PS, Nibbering PH, van Dissel JT (2003) Plasma secretory leukocyte protease inhibitor in febrile patients. Clin Microbiol Infect 9(7):605\u2013613","journal-title":"Clin Microbiol Infect"},{"issue":"3\u20134","key":"3567_CR35","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1515\/znc-2001-3-420","volume":"56","author":"A Mihaila","year":"2001","unstructured":"Mihaila A, Tremblay GM (2001) Human alveolar macrophages express elafin and secretory leukocyte protease inhibitor. Z Naturforsch C 56(3\u20134):291\u2013297","journal-title":"Z Naturforsch C"},{"key":"3567_CR36","doi-asserted-by":"crossref","unstructured":"Persson LJ, Aanerud M, Hardie JA, Miodini Nilsen R, Bakke PS, Eagan TM, Hiemstra PS (2017) Antimicrobial peptide levels are linked to airway inflammation, bacterial colonisation and exacerbations in chronic obstructive pulmonary disease. Eur Respir J 49(3):1601328","DOI":"10.1183\/13993003.01328-2016"},{"issue":"5","key":"3567_CR37","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1189\/jlb.0706442","volume":"83","author":"LC Jacobsen","year":"2008","unstructured":"Jacobsen LC, Sorensen OE, Cowland JB, Borregaard N, Theilgaard-Monch K (2008) The secretory leukocyte protease inhibitor (SLPI) and the secondary granule protein lactoferrin are synthesized in myelocytes, colocalize in subcellular fractions of neutrophils, and are coreleased by activated neutrophils. J Leukoc Biol 83(5):1155\u20131164","journal-title":"J Leukoc Biol"},{"issue":"4","key":"3567_CR38","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1002\/hep.26933","volume":"59","author":"CG Antoniades","year":"2014","unstructured":"Antoniades CG, Khamri W, Abeles RD, Taams LS, Triantafyllou E, Possamai LA, Bernsmeier C, Mitry RR, O'Brien A, Gilroy D, Goldin R, Heneghan M, Heaton N, Jassem W, Bernal W, Vergani D, Ma Y, Quaglia A, Wendon J, Thursz M (2014) Secretory leukocyte protease inhibitor: a pivotal mediator of anti-inflammatory responses in acetaminophen-induced acute liver failure. Hepatology 59(4):1564\u20131576","journal-title":"Hepatology"},{"issue":"3","key":"3567_CR39","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.it.2013.10.006","volume":"35","author":"JG Markle","year":"2014","unstructured":"Markle JG, Fish EN (2014) SeXX matters in immunity. Trends Immunol 35(3):97\u2013104","journal-title":"Trends Immunol"},{"issue":"Suppl 3","key":"3567_CR40","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1093\/infdis\/jiu232","volume":"209","author":"M Muenchhoff","year":"2014","unstructured":"Muenchhoff M, Goulder PJ (2014) Sex differences in pediatric infectious diseases. J Infect Dis 209(Suppl 3):S120\u2013S126","journal-title":"J Infect Dis"},{"issue":"10","key":"3567_CR41","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1007\/s00134-003-1948-z","volume":"29","author":"L Bindl","year":"2003","unstructured":"Bindl L, Buderus S, Dahlem P, Demirakca S, Goldner M, Huth R, Kohl M, Krause M, Kuhl P, Lasch P, Lewandowski K, Merz U, Moeller J, Mohamad Y, Peters M, Porz W, Vierzig A, Ruchard J, Scharf J, Varnholt V (2003) Gender-based differences in children with sepsis and ARDS: the ESPNIC ARDS Database Group. Intensive Care Med 29(10):1770\u20131773","journal-title":"Intensive Care Med"},{"issue":"9","key":"3567_CR42","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.rmed.2007.04.011","volume":"101","author":"ME Falagas","year":"2007","unstructured":"Falagas ME, Mourtzoukou EG, Vardakas KZ (2007) Sex differences in the incidence and severity of respiratory tract infections. Respir Med 101(9):1845\u20131863","journal-title":"Respir Med"},{"issue":"2","key":"3567_CR43","doi-asserted-by":"crossref","first-page":"L166","DOI":"10.1152\/ajplung.00119.2015","volume":"310","author":"C Draijer","year":"2016","unstructured":"Draijer C, Hylkema MN, Boorsma CE, Klok PA, Robbe P, Timens W, Postma DS, Greene CM, Melgert BN (2016) Sexual maturation protects against development of lung inflammation through estrogen. Am J Physiol Lung Cell Mol Physiol 310(2):L166\u2013L174","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"2","key":"3567_CR44","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.bbrc.2003.08.151","volume":"310","author":"AE King","year":"2003","unstructured":"King AE, Morgan K, Sallenave JM, Kelly RW (2003) Differential regulation of secretory leukocyte protease inhibitor and elafin by progesterone. Biochem Biophys Res Commun 310(2):594\u2013599","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"3567_CR45","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1164\/rccm.201001-0053OC","volume":"182","author":"SH Chotirmall","year":"2010","unstructured":"Chotirmall SH, Greene CM, Oglesby IK, Thomas W, O'Neill SJ, Harvey BJ, McElvaney NG (2010) 17Beta-estradiol inhibits IL-8 in cystic fibrosis by up-regulating secretory leucoprotease inhibitor. Am J Respir Crit Care Med 182(1):62\u201372","journal-title":"Am J Respir Crit Care Med"},{"issue":"36","key":"3567_CR46","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1038\/onc.2016.13","volume":"35","author":"D Zheng","year":"2016","unstructured":"Zheng D, Gui B, Gray KP, Tinay I, Rafiei S, Huang Q, Sweeney CJ, Kibel AS, Jia L (2016) Secretory leukocyte protease inhibitor is a survival and proliferation factor for castration-resistant prostate cancer. Oncogene 35(36):4807\u20134815","journal-title":"Oncogene"},{"issue":"3","key":"3567_CR47","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/ni1434","volume":"8","author":"W Xu","year":"2007","unstructured":"Xu W, He B, Chiu A, Chadburn A, Shan M, Buldys M, Ding A, Knowles DM, Santini PA, Cerutti A (2007) Epithelial cells trigger frontline immunoglobulin class switching through a pathway regulated by the inhibitor SLPI. Nat Immunol 8(3):294\u2013303","journal-title":"Nat Immunol"},{"issue":"9","key":"3567_CR48","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/j.1469-0691.2007.01775.x","volume":"13","author":"F Jaureguy","year":"2007","unstructured":"Jaureguy F, Carbonnelle E, Bonacorsi S, Clec'h C, Casassus P, Bingen E, Picard B, Nassif X, Lortholary O (2007) Host and bacterial determinants of initial severity and outcome of Escherichia coli sepsis. Clin Microbiol Infect 13(9):854\u2013862","journal-title":"Clin Microbiol Infect"}],"container-title":["European Journal of Clinical Microbiology &amp; Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-019-03567-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-019-03567-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-019-03567-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,12]],"date-time":"2020-12-12T20:55:39Z","timestamp":1607806539000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-019-03567-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,14]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["3567"],"URL":"https:\/\/doi.org\/10.1007\/s10096-019-03567-2","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,14]]},"assertion":[{"value":"6 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval was achieved from the Regional Ethics Review Board of Uppsala, Sweden (02\/25\/2009, file number 2009\/024), and the study was conducted in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from the patient or relative.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}